Bioanalytical methods for the determination of cocaine and metabolites in human biological samples

Bibliography

• 1  Kolbrich EA, Barnes AJ, Gorelick DA et al. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J. Anal. Toxicol.30,501–510 (2006).
  Medline CASGoogle Scholar
• 2  Boghdadi MS, Henning RJ. Cocaine: pathophysiology and clinical toxicology. Heart Lung26,466–483 (1997).
  Medline CASGoogle Scholar
• 3  Goldstein RA, DesLauries C, Burda MA. Cocaine: history, social implications, and toxicity – a review. Dis. Mon.55,6–38 (2009).
  MedlineGoogle Scholar
• 4  Spihler V. Drugs in saliva. In: Clarke’s Analysis of Drugs and Poisons. Pharmaceutical Press, London, UK 109–123 (2004).
  Google Scholar
• 5  Baselt RC. Disposition of Toxic Drugs and Chemicals in Man (7th Edition). Biomedical Publications, CA, USA 256–262 (2004).
  Google Scholar
• 6  Cognard E, Bouchonnet S, Staub C. Validation of a gas chromatography–ion trap tandem mass spectrometry for simultaneous analyse of cocaine and its metabolites in saliva. J. Pharm. Biomed. Anal.41,925–934 (2006).
  Medline CASGoogle Scholar
• 7  Huestis MA, Darwin WD, Shimomura E et al. Cocaine and metabolites urinary excretion after controlled smoked administration. J. Anal. Toxicol.31,462–468 (2007).
  Medline CASGoogle Scholar
• 8  Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. J. Pharmacol. Exp. Ther.313,909–915 (2005).
  Medline CASGoogle Scholar
• 9  Zuo Y, Zhang K, Wu J, Rego C, Fritz J. An accurate and non-destructive GC method for determination of cocaine on US paper currency. J. Sep. Sci.31,2444–2450 (2008).
  Medline CASGoogle Scholar
• 10  Bones J, Macka M, Paull B. Evaluation of monolithic and sub 2 µm particle packed columns for the rapid screening for illicit drugs – application to the determination of drug contamination on Irish euro banknotes. Analyst132,208–17 (2007).
  Medline CASGoogle Scholar
• 11  Jenkins AJ. Drug contamination of US paper currency. Forensic Sci. Int.121,189–193 (2001).
  Medline CASGoogle Scholar
• 12  Sergi M, Bafile E, Compagnone D, Curini R, D’Ascenzo G, Romolo FS. Multiclass analysis of illicit drugs in plasma and oral fluids by LC–MS/MS. Anal. Bioanal. Chem.393,709–718 (2009).
  Medline CASGoogle Scholar
• 13  Verstraete AG. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug. Monit.26,200–205 (2004).
  Medline CASGoogle Scholar
• 14  Keller T, Keller A, Tutsch-Bauer E, Monticelli F. Driving under the influence of drugs and alcohol in Salzburg and Uppper Austria during the years 2003–2007. Leg. Med.11,S98–S99 (2009).
  MedlineGoogle Scholar
• 15  Tóth AR, Varga T, Molnár A, Hideg Z, Somogi G. The role of licit and illicit drugs in traffic (Hungary 2000–2007). Leg. Med. 11,S419–S422 (2009).
  MedlineGoogle Scholar
• 16  Jones AW, Holmgren A, Kugelberg FC. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden. Forensic Sci. Int.177,133–139 (2008).
  Medline CASGoogle Scholar
• 17  Yonamine M, Saviano AM. Determination of cocaine and cocaethylene in urine by solid-phase microextraction and gas chromatography–mass spectrometry. Biomed. Chromatogr.20,1071–1075 (2006).
  Medline CASGoogle Scholar
• 18  Dolan K, Rouen D, Kimber J. An overview of the use of urine, hair, sweat and saliva to detect drug use. Drug Alcohol Rev.23,213–217 (2004).
  MedlineGoogle Scholar
• 19  Farell LJ, Kerrigan S, Logan BK. Recommendations for toxicological investigation of drug impaired driving. J. Forensic Sci.52,1214–1218 (2007).
  MedlineGoogle Scholar
• 20  Jaffee WB, Trucco E, Teter C, Levy S, Weiss RD. Focus on alcohol and drug abuse: ensuring validity in urine drug testing. Psychiatr. Serv.59,140–142 (2008).
  MedlineGoogle Scholar
• 21  Cook JD, Caplan YH, LoDico CP, Bush DM. The characterization of human urine for specimen validity determination in workplace drug testing: a review. J. Anal. Toxicol.24,579–588 (2000).
  Medline CASGoogle Scholar
• 22  Gallardo E, Queiroz JA. The role of alternative specimens in toxicological analysis. Biomed. Chromatogr.22,795–821 (2008).
  Medline CASGoogle Scholar
• 23  Barroso M, Dias M, Vieira DN, Queiroz JA, López-Rivadulla M. Development and validation of an analytical method for the simultaneous determination of cocaine and its main metabolite, benzoylecgonine, in human hair by gas chromatography/mass spectrometry. Rapid Commun. Mass Spectrom.22,3320–3326 (2008).
  Medline CASGoogle Scholar
• 24  Musshoff F, Madea B. Analytical pitfalls in hair testing. Anal. Bioanal. Chem.388,1475–1494 (2007).
  Medline CASGoogle Scholar
• 25  Society of Hair Testing: Recommendations for hair testing in forensic cases. Forensic Sci. Int.145,83–84 (2004).
  MedlineGoogle Scholar
• 26  Hill V, Cairns T, Schaffer M. Hair analysis for cocaine: factors in laboratory contamination studies and their relevance to proficiency sample preparation and hair testing practices. Forensic Sci. Int.176,23–33 (2008).
  Medline CASGoogle Scholar
• 27  Hill V, Cairns T, Schaffer M. Hair analysis for cocaine: the requirement for effective wash procedures and effects of drug concentration and hair porosity in contamination and decontamination. J. Anal. Toxicol.29,319–326 (2005).
  MedlineGoogle Scholar
• 28  Blank DL, Kidwell DA. Decontamination procedures for drugs of abuse in hair: are they sufficient? Forensic Sci. Int.70,13–38 (1995).
  Medline CASGoogle Scholar
• 29  Hoelzle C, Scheufler F, Uhl M, Sachs H, Thieme D. Application of discriminant analysis to differentiate between incorporation of cocaine and its congeners into hair and contamination. Forensic Sci. Int.176,13–18 (2008).
  Medline CASGoogle Scholar
• 30  Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs – evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci. Int.152,149–155 (2005).
  Medline CASGoogle Scholar
• 31  Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G. Cognition and motor control as a function of D9-THC concentration in serum and oral fluid: Limits of impairment. Drug Alcohol Depend.85,114–122 (2006).
  Medline CASGoogle Scholar
• 32  Drummer OH. Review: pharmacokinetics of illicit drugs in oral fluid. Forensic Sci. Int.150,133–142 (2005).
  Medline CASGoogle Scholar
• 33  Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J. Chromatogr.B733,247–264 (1999).
  Google Scholar
• 34  Kidwell DA, Smith FP. Susceptibility of PharmChek™ drugs of abuse patch to environmental contamination. Forensic Sci. Int.116,89–106 (2001).
  Medline CASGoogle Scholar
• 35  Gray T, Huestis M. Bioanalytical procedures for monitoring in utero drug exposure. Anal. Bioanal. Chem.388,1455–1465 (2007).
  Medline CASGoogle Scholar
• 36  Lozano J, García-Algar O, Vall O, de la Torre R, Scaravelli G, Pichini S. Biological matrices for the evaluation of in uteroexposure to drugs of abuse. Ther. Drug Monit.29,711–734 (2007).
  Medline CASGoogle Scholar
• 37  Huestis MA, Choo RE. Drug abuse’s smallest victims: in utero drug exposure. Forensic Sci. Int.128,20–30 (2002).
  MedlineGoogle Scholar
• 38  Gareri J, Klein J, Koren G. Drugs of abuse testing in meconium. Clin. Chim. Acta366,101–111 (2006).
  Medline CASGoogle Scholar
• 39  Ostrea EM Jr: Testing for exposure to illicit drugs and other agents in the neonate: a review of laboratory methods and the role of meconium analysis. Curr. Probl. Pediatr.29,37–56 (1999).
  MedlineGoogle Scholar
• 40  Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J. Chromatogr.B713,137–146 (1998).
  Google Scholar
• 41  Montgomery DP, Plate CA, Jones M et al. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered stuffy in Utah and New Jersey. J. Perionatol.28,750–753 (2008).
  Medline CASGoogle Scholar
• 42  Eyler FD, Behnke M, Wobie K, Garvan CW, Tebbett I. Relative ability of biologic specimens and interviews to detect prenatal cocaine use. Neurotoxicol. Teratol.27,677–687 (2005).
  Medline CASGoogle Scholar
• 43  Kim E, Brion LP, Meenan G, Lehrer M, Suresh BR. Perinatal toxicology screening: comparison of various maternal and neonatal samples. J. Perinatol.18,116–121 (1998).
  Medline CASGoogle Scholar
• 44  Winecker RE, Goldberger BA, Tebbett I et al. Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue. J. Anal. Toxicol.21,97–104 (1997).
  Medline CASGoogle Scholar
• 45  Moore C, Browne S, Tebbett I, Negruzs A, Meyer W, Jain L. Determination of cocaine and benzoylecgonine in human aminiotic fluid using high flow solid-phase extraction columns and HPLC. Forensic Sci. Int.56,177–181 (1992).
  Medline CASGoogle Scholar
• 46  Moore C, Dempsey D, Deitermann D, Lewis D, Leikin J. Fetal cocaine exposure: analysis of vernix caseosa. J. Anal. Toxicol.20,509–511 (1992).
  Google Scholar
• 47  Contreras MT, González M, González S et al. Validation of a procedure for the gas chromatography–mass spectrometry analysis of cocaine and metabolites in pericardial fluid. J. Anal. Toxicol.31,75–80 (2007).
  Medline CASGoogle Scholar
• 48  Contreras MT, Hernández AF, González M. Application of pericardial fluid to the analysis of morphine (heroin) and cocaine in forensic toxicology. Forensic Sci. Int.164,168–171 (2006).
  Medline CASGoogle Scholar
• 49  Duer WC, Spitz DJ, McFarland S. Relationships between concentrations of cocaine and its hydrolysates in peripheral blood, heart blood, vitreous humor and urine. J. Forensic Sci.51,421–425 (2006).
  Medline CASGoogle Scholar
• 50  Fucci N, De Giovanni N, De Giorgio F, Liddi R, Chiarotti M. An evaluation of the Cozart^® RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor. Forensic Sci. Int.156,102–105 (2006).
  Medline CASGoogle Scholar
• 51  Fernández P, Aldonza M, Bouzas A, Lema M, Bermejo AM, Tabernero MJ. GC-FID determination of cocaine and its metabolites in human bile and vitreous humor. J. Appl. Toxicol.26,253–257 (2006).
  Medline CASGoogle Scholar
• 52  Furnari C, Ottaviano V, Sacchetti G, Mancini M. A fatal case of cocaine poisoning in a body packer. J. Forensic Sci.47,208–210 (2002).
  MedlineGoogle Scholar
• 53  Chronister CW, Walrath JC, Goldberger BA. Rapid detection of benzoylecgonine in vitreous humor by enzyme immunoassay. J. Anal. Toxicol.25,621–624 (2001).
  Medline CASGoogle Scholar
• 54  Mackey-Bojack S, Kloss J, Apple F. Cocaine, cocaine metabolite, and ethanol concentrations in postmortem blood and vitreous humor. J. Anal. Toxicol.24,59–65 (2000).
  Medline CASGoogle Scholar
• 55  McKinney PE, Phillips S, Gomez HF, Brent J, MacIntyre M, Watson WA. Vitreous humor cocaine and metabolite concentrations: do postmortem specimens reflect blood levels at the time of death?. J. Forensic Sci.40,102–107 (1995).
  Medline CASGoogle Scholar
• 56  Logan BK, Stafford DT. High-performance liquid chromatography with column switching for the determination of cocaine and benzoylecgonine concentrations in vitreous humor. J. Forensic Sci.35,1303–1309 (1990).
  Medline CASGoogle Scholar
• 57  Mari F, Politi L, Bertol E. Nails of newborns in monitoring drug exposure during pregnancy. Forensic Sci. Int.179,176–180 (2008).
  Medline CASGoogle Scholar
• 58  Ragoucy-Sengler C, Kintz P. Detection of smoked cocaine marker (anhydroecgonine methylester) in nails. J. Anal. Toxicol.29,765–768 (2005).
  Medline CASGoogle Scholar
• 59  Valente-Campos S, Yonamine M, de Moraes Moreau RL, Silva AO. Validation of a method to detect cocaine and its metabolites in nails by gas chromatography–mass spectrometry. Forensic Sci. Int.159,218–222 (2006).
  Medline CASGoogle Scholar
• 60  Cingolani M, Scavella S, Mencarelli R, Mirtella D, Froldi R, Rodriguez D. Simultaneous detection and quantitation of morphine, 6-acetylmorphine, and cocaine in toenails: comparison with hair analysis. J. Anal. Toxicol.28,128–131 (2004).
  Medline CASGoogle Scholar
• 61  Engelhart DA, Jenkins AJ. Detection of cocaine analytes and opiates in nails from postmortem cases. J. Anal. Toxicol.26,489–492 (2002).
  Medline CASGoogle Scholar
• 62  Ropero-Miller JD, Goldberger BA, Cone EJ, Joseph RE Jr. The disposition of cocaine and opiate analytes in hair and fingernails of humans following cocaine and codeine administration. J. Anal. Toxicol.24,496–508 (2000).
  Medline CASGoogle Scholar
• 63  Garside D, Ropero-Miller JD, Goldberger BA, Hamilton WF, Maples WR. Identification of cocaine analytes in fingernail and toenail specimens. Forensic Sci.43,974–979 (1998).
  CASGoogle Scholar
• 64  Engelhart DA, Lavins ES, Sutheimer CA. Detection of drugs of abuse in nails. J. Anal. Toxicol.22,314–318 (1998).
  Medline CASGoogle Scholar
• 65  Skopp G, Pötsch L. A case report on drug screening of nail clippings to detect prenatal drug exposure. Ther. Drug Monit.19,386–389 (1997).
  Medline CASGoogle Scholar
• 66  McGrath KK, Jenkins AJ. Detection of drugs of forensic importance in postmortem bone. Am. J. Forensic Med. Pathol.30,40–44 (2009).
  MedlineGoogle Scholar
• 67  Poklis A, Maginn D, Barr JL. Tissue disposition of cocaine in man: a report of five fatal poisonings. Forensic Sci. Int.33,83–88 (1987).
  Medline CASGoogle Scholar
• 68  Giroud C, Michaud K, Sporkert F et al. A fatal overdose of cocaine associated with coingestion of marijuana, buprenorphine, and fluoxetine. Body fluid and tissue distribution of cocaine and its metabolites determined by hydrophilic interaction chromatography-mass spectrometry (HILIC–MS). J. Anal. Toxicol.28,464–474 (2004).
  Medline CASGoogle Scholar
• 69  Vanbinst R, Koenig J, Di Fazio V, Hassoun A. Bile analysis of drugs in postmortem cases. Forensic Sci. Int.128,35–40 (2002).
  Medline CASGoogle Scholar
• 70  Soriano T, Jurado C, Menéndez M, Repetto M. Improved solid-phase extraction method for systematic toxicological analysis in biological fluids. J. Anal. Toxicol.25,137–143 (2001).
  Medline CASGoogle Scholar
• 71  Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass. Anal. Bioanal. Chem.394(2),513–522 (2009).
  MedlineGoogle Scholar
• 72  Yang W, Barnes AJ, Ripple MG et al. Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography–mass spectrometry. J. Chromatogr.B833,210–218 (2006).
  Google Scholar
• 73  Lester L, Uemura N, Ademola J et al. Disposition of cocaine in skin, interstitial fluid, sebum, and stratum corneum. J. Anal. Toxicol.26,547–553 (2002).
  Medline CASGoogle Scholar
• 74  Levisky JA, Bowerman DL, Jenkins WW, Karch SB. Drug deposition in adipose tissue and skin: evidence for an alternative source of positive sweat patch tests. Forensic Sci. Int.110,35–46 (2000).
  Medline CASGoogle Scholar
• 75  Burillo-Putze G, López B, León JM et al. Undisclosed cocaine use and chest pain in emergency departments of Spain. Scand. J. Trauma Resusc. Emerg. Med.17,11 (2009).
  MedlineGoogle Scholar
• 76  Holmgren A, Holmgren P, Kugelberg FC, Jones AW, Ahlner J. Predominance of illicit drugs and poly-drug use among drug-impaired drivers in Sweden. Traffic Inj. Prev.8,361–367 (2007).
  MedlineGoogle Scholar
• 77  Garcia-Jimenez S, Heredia-Lezama K, Bilbao-Marcos F, Fuentes-Lara G, Monroy-Noyola A, Deciga-Campos M. Screening for marijuana and cocaine abuse by immunoanalysis and gas chromatography. Ann. NY Acad. Sci.1139,422–425 (2008).
  Medline CASGoogle Scholar
• 78  Baker JE, Jenkins AJ. Screening for cocaine metabolite fails to detect an intoxication. Am. J. Forensic Med. Pathol.29,141–144 (2008).
  MedlineGoogle Scholar
• 79  Farrell LJ, Kerrigan S, Logan BK. Recommendations for toxicological investigation of drug impaired driving. Forensic Sci.52,1214–1218 (2007).
  CASGoogle Scholar
• 80  Labat L, Fontaine B, Delzenne C et al. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France). Forensic Sci. Int.174,90–94 (2008).
  Medline CASGoogle Scholar
• 81  Lu NT, Taylor BG. Drug screening and confirmation by GC–MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories. Forensic Sci. Int.157,106–116 (2006).
  Medline CASGoogle Scholar
• 82  Cone EJ, Sampson-Cone AH, Darwin WD, Huestis MA, Oyler JM. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results. J. Anal. Toxicol.27,386–401 (2003).
  Medline CASGoogle Scholar
• 83  Feldman M, Kuntz D, Botelho K et al. Evaluation of Roche Diagnostics ONLINE DAT II, a new generation of assays for the detection of drugs of abuse. J. Anal. Toxicol.28,593–598 (2004).
  Medline CASGoogle Scholar
• 84  Ch’ng CW, Fitzgerald M, Gerostamoulos J et al. Drug use in motor vehicle drivers presenting to an Australian, adult major trauma centre. Emerg. Med. Australas.19,359–365 (2007).
  MedlineGoogle Scholar
• 85  Spiehler V, Isenschmid DS, Matthews P, Kemp P, Kupiec T. Performance of a microtiter plate ELISA for screening of postmortem blood for cocaine and metabolites. J. Anal Toxicol.27,587–591 (2003).
  Medline CASGoogle Scholar
• 86  Lillsunde P, Michelson L, Forsstrom T et al. Comprehensive drug screening in blood for detecting abused drugs or drugs potentially hazardous for traffic safety. Forensic Sci. Int.77,191–210 (1996).
  Medline CASGoogle Scholar
• 87  Poklis A, Jortani S, Edinboro LE, Saady JJ. Direct determination of benzoylecgonine in serum by EMIT d.a.u. cocaine metabolite immunoassay. J. Anal Toxicol.18,419–422 (1994).
  Medline CASGoogle Scholar
• 88  Bogusz M, Aderjan R, Schmitt G, Nadler E, Neureither B. The determination of drugs of abuse in whole blood by means of FPIA and EMIT-dau immunoassays – a comparative study. Forensic Sci. Int.48,27–37 (1990).
  Medline CASGoogle Scholar
• 89  Pujol ML, Cirimele V, Tritsch PJ, Villain M, Kintz P. Evaluation of the IDS One-step ELISA kits for the detection of illicit drugs in hair. Forensic Sci. Int.170,189–192 (2007).
  Medline CASGoogle Scholar
• 90  Tsanaclis L, Wicks JF. Patterns in drug use in the United Kingdom as revealed through analysis of hair in a large population sample. Forensic Sci. Int. Aug 170,121–128 (2007).
  Medline CASGoogle Scholar
• 91  Lachenmeier K, Musshoff F, Madea B. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic–mass spectrometric (GC–MS) confirmation. Forensic Sci. Int.159,189–199 (2006).
  Medline CASGoogle Scholar
• 92  Garcia-Bournissen F, Nesterenko M, Karaskov T, Koren G. Passive environmental exposure to cocaine in Canadian children. Paediatr.11,30–32 (2009).
  Google Scholar
• 93  Quintela O, Bermejo AM, Tabernero MJ, Strano-Rossi S, Chiarotti M, Lucas AC. Evaluation of cocaine, amphetamines and cannabis use in university students through hair analysis: preliminary results. Forensic Sci. Int.107,273–279 (2000).
  Medline CASGoogle Scholar
• 94  Tagliaro F, Valentini R, Manetto G, Crivellente F, Carli G, Marigo M. Hair analysis by using radioimmunoassay, high-performance liquid chromatography and capillary electrophoresis to investigate chronic exposure to heroin, cocaine and/or ecstasy in applicants for driving licences. Forensic Sci. Int.107,121–128 (2000).
  Medline CASGoogle Scholar
• 95  Moore C, Deitermann D, Lewis D, Feeley B, Niedbala RS. The detection of cocaine in hair specimens using micro-plate enzyme immunoassay. J. Forensic Sci.44,609–612 (1999).
  Medline CASGoogle Scholar
• 96  Segura J, Stramesi C, Redón A et al. Immunological screening of drugs of abuse and gas chromatographic–mass spectrometric confirmation of opiates and cocaine in hair. J. Chromatogr.B724,9–21 (1999).
  Google Scholar
• 97  Niedbala RS, Kardos K, Fries T, Cannon A, Davis A. Immunoassay for detection of cocaine/metabolites in oral fluids. J. Anal. Toxicol.25,62–68 (2001).
  Medline CASGoogle Scholar
• 98  Cooper G, Wilson L, Reid C, Baldwin D, Main L, Hand C. Evaluation of the Cozart^® RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Sci. Int.150,239–243 (2005).
  Medline CASGoogle Scholar
• 99  Kim I, Barnes AJ, Schepers R et al. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clin. Chem.49,498–1503 (2003).
  Google Scholar
• 100  Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spieher V. Validation of the Cozart^® microplate EIA for cocaine and metabolites in oral fluid. J. Anal. Toxicol.28,498–503 (2004).
  Medline CASGoogle Scholar
• 101  Kolbrich EA, Kim I, Barnes AJ et al. Cozart^® RapiScan oral fluid drug testing system: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC–MS following controlled cocaine administration. J. Anal. Toxicol.27,407–411(2003).
  Medline CASGoogle Scholar
• 102  Grönholm M, Lillsunde P. A comparison between on-site immunoassay drug-testing devices and laboratory results. Forensic Sci. Int.121,37–46 (2001).
  Medline CASGoogle Scholar
• 103  Peace MR, Tarnai LD, Poklis A. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine. J. Anal. Toxicol.24,589–594 (2000).
  Medline CASGoogle Scholar
• 104  Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci. Int.150,143–150 (2005).
  Medline CASGoogle Scholar
• 105  Biermann T, Schwarze B, Zedler B, Betz P. On-site testing of illicit drugs: the use of the drug-testing device ‘Toxiquick’. Forensic Sci. Int.143,21–25 (2004).
  Medline CASGoogle Scholar
• 106  Kacinko SL, Barnes AJ, Kim I et al. Performance characteristics of the Cozart^® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci. Int.141,41–48 (2004).
  Medline CASGoogle Scholar
• 107  Barrett C, Good C, Moore C. Comparison of point of collection screening of drugs of abuse in oral fluid with a laboratory based urine screen. Forensic Sci. Int.122,163–166 (2001).
  Medline CASGoogle Scholar
• 108  Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J. An evaluation of rapid point-of collection oral fluid drug-testing devices. J. Anal. Toxicol.27,429–439 (2003).
  Medline CASGoogle Scholar
• 109  Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Anal. Bioanal. Chem. in press (2009).
  MedlineGoogle Scholar
• 110  Antonides HM, Kiely ER, Marinetti LJ. Vitreous fluid quantification of opiates, cocaine, and benzoylecgonine: comparison of calibration curves in both blood and vitreous matrices with corresponding concentrations in blood. J. Anal. Toxicol.31,469–476 (2007).
  Medline CASGoogle Scholar
• 111  Pehrsson A, Gunnar T, Engblom C, Seppä H, Jama A, Lillsunde P. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci. Int.175,140–148 (2008).
  Medline CASGoogle Scholar
• 112  Concheiro M, de Castro A, Quintela O, López-Rivadulla M, Cruz A. Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography–mass spectrometry. An application to 156 road fatalities. J. Chromatogr.B832,81–89 (2006).
  Google Scholar
• 113  Maralikova B, Weinmann W. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography–tandem mass spectrometry with respect to criteria for compound identification. J. Chromatogr B8111,21–30 (2004).
  Google Scholar
• 114  Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography–mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Anal. Bioanal. Chem.392,115–127 (2008).
  Medline CASGoogle Scholar
• 115  Robandt PP, Reda LJ, Klette KL. Complete automation of solid-phase extraction with subsequent liquid chromatography–tandem mass spectrometry for the quantification of benzoylecgonine, m-hydroxybenzoylecgonine, p-hydroxybenzoylecgonine, and norbenzoylecgonine in urine-application to a high-throughput urine analysis laboratory. J. Anal. Toxicol.32,577–585 (2008).
  Medline CASGoogle Scholar
• 116  Cone EJ, Caplan YH, Black DL, Robert T, Moser F. Urine drug testing of chronic pain patients: licit and illicit drug patterns. J. Anal. Toxicol.32,530–543 (2008).
  Medline CASGoogle Scholar
• 117  Gunnar T, Ariniemi K, Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J. Mass Spectrom.40,739–753 (2005).
  Medline CASGoogle Scholar
• 118  Saito T, Mase H, Takeichi S, Inokuchi S. Rapid simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates in human urine by GC–MS. J. Pharm. Biomed. Anal.43,358–363 (2007).
  Medline CASGoogle Scholar
• 119  Strano-Rossi S, Colamonici C, Botre F. Parallel analysis of stimulants in saliva and urine by gas chromatography/mass spectrometry: perspectives for ‘in competition’ anti-doping analysis. Anal. Chim. Acta606,217–222 (2008).
  Medline CASGoogle Scholar
• 120  Kala SV, Harris SE, Freijo TD, Gerlich S. Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography–tandem mass spectrometry. J. Anal. Toxicol.32,605–611 (2008).
  Medline CASGoogle Scholar
• 121  Gottardo R, Bortolotti F, De Paoli G, Pascali JP, Miksík I, Tagliaro F. Hair analysis for illicit drugs by using capillary zone electrophoresis–electrospray ionization–ion trap mass spectrometry. J. Chromatogr. A1159,185–189 (2007)
  Medline CASGoogle Scholar
• 122  Øiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography–tandem mass spectrometry. Clin. Chem.53,300–309 (2007).
  MedlineGoogle Scholar
• 123  Bermejo AM, López P, Alvarez I, Tabernero MJ, Fernández P. Solid-phase microextraction for the determination of cocaine and cocaethylene in human hair by gas chromatography-mass spectrometry. Forensic Sci. Int.156,2–8 (2006).
  Medline CASGoogle Scholar
• 124  de Toledo FC, Yonamine M, de Moraes Moreau RL, Silva OA. Determination of cocaine, benzoylecgonine and cocaethylene in human hair by solid-phase microextraction and gas chromatography–mass spectrometry. J. Chromatogr.B798,361–365 (2003).
  Google Scholar
• 125  Alvarez I, Bermejo AM, Tabernero MJ, Fernández P, López P. Determination of cocaine and cocaethylene in plasma by solid-phase microextraction and gas chromatography–mass spectrometry. J. Chromatogr.B845,90–94 (2007).
  Google Scholar
• 126  Follador MJ, Yonamine M, de Moraes Moreau RL, Silva OA. Detection of cocaine and cocaethylene in sweat by solid-phase microextraction and gas chromatography/mass spectrometry. J. Chromatogr. B811,37–40 (2004).
  Medline CASGoogle Scholar
• 127  Gentili S, Cornetta M, Macchia T. Rapid screening procedure based on headspace solid-phase microextraction and gas chromatography–mass spectrometry for the detection of many recreational drugs in hair. J. Chromatogr.B801,289–296 (2004).
  Google Scholar
• 128  Pragst F. Application of solid-phase microextraction in analytical toxicology. Anal. Bioanal. Chem.388,1393–414 (2007).
  Medline CASGoogle Scholar
• 129  Radcliffe C, Maguire K, Lockwood B. Applications of supercritical fluid extraction and chromatography in forensic science. J. Biochem. Biophys. Methods43,261–272 (2000).
  Medline CASGoogle Scholar
• 130  Allen DL, Oliver JS. The application of supercritical fluid extraction to cocaine and its metabolites in blood and urine. J. Anal. Toxicol.24,228–232 (2000).
  Medline CASGoogle Scholar
• 131  Kintz P. Bioanalytical procedures for detection of chemical agents in hair in the case of drug-facilitated crimes. Anal. Bioanal. Chem.388,1467–1474 (2007).
  Medline CASGoogle Scholar
• 132  Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin. Chim. Acta370,17–49 (2006).
  Medline CASGoogle Scholar
• 133  Huang DK, Liu C, Huang MK, Chien CS. Simultaneous determination of morphine, codeine, 6-acetylmorphine, cocaine and benzoylecgonine in hair by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom.23,957–962 (2009).
  Medline CASGoogle Scholar
• 134  Musshoff F, Lachenmeier K, Lichtermann D, Madea B. Cocaine and opiate concentrations in hair from subjects in a heroin maintenance program in comparison to a methadone substituted group. Int. J. Legal Med. (2008) (Epub ahead of print).
  Google Scholar
• 135  Moore C, Coulter C, Crompton K. Determination of cocaine, benzoylecgonine, cocaethylene and norcocaine in human hair using solid-phase extraction and liquid chromatography with tandem mass spectrometric detection. J. Chromatogr.B859,208–212 (2007).
  Google Scholar
• 136  Gottardo R, Polettini A, Sorio D et al. Capillary zone electrophoresis (CZE) coupled to time-of-flight mass spectrometry (TOF–MS) applied to the analysis of illicit and controlled drugs in blood. Electrophoresis29,4078–4087 (2008).
  Medline CASGoogle Scholar
• 137  Jagerdeo E, Montgomery MA, Lebeau MA, Sibum M. An automated SPE/LC/MS/MS method for the analysis of cocaine and metabolites in whole blood. J. Chromatogr.B874,15–20 (2008).
  Google Scholar
• 138  Bertol E, Trignano C, Di Milia MG, Di Padua M, Mari F. Cocaine-related deaths: An enigma still under investigation. Forensic Sci. Int.176,121–123 (2008).
  Medline CASGoogle Scholar
• 139  Fernández P, Lago M, Lorenzo RA, Carro AM, Bermejo AM, Tabernero MJ. Microwave-Assisted Extraction and HPLC–DAD determination of drugs of Abuse in human plasma. J. Anal. Toxicol.31,388–393 (2007).
  Medline CASGoogle Scholar
• 140  Johansen SS, Bhatia HM. Quantitative analysis of cocaine and its metabolites in whole blood and urine by high-performance liquid chromatography coupled with tandem mass spectrometry. J. Chromatogr.B852,338–344 (2007).
  Google Scholar
• 141  Alvarez I, Bermejo AM, Tabernero MJ, Fernández P, López P. Determination of cocaine and cocaethylene in plasma by solid-phase microextraction and gas chromatography–mass spectrometry. J. Chromatogr.B845,90–94 (2007).
  Google Scholar
• 142  Cardona PS, Chaturvedi AK, Soper JW, Canfield DV. Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products. Forensic Sci. Int.157,46–56 (2006).
  Medline CASGoogle Scholar
• 143  Fernández P, Morales L, Vázquez C, Bermejo AM, Tabernero MJ. HPLC–DAD determination of opioids, cocaine and their metabolites in plasma. Forensic Sci. Int.161,31–35 (2006).
  Medline CASGoogle Scholar
• 144  Jagerdeo E, Abdel-Rehim M. Screening of cocaine and its metabolites in human urine samples by direct analysis in real-time source coupled to time-of-flight mass spectrometry after anline preconcentration utilizing microextraction by packed sorbent. J. Am. Soc. Mass Spectrom.20(5),891–899 (2009).
  Medline CASGoogle Scholar
• 145  Berg T, Lundanes E, Christophersen AS, Strand DH. Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC–MS/MS. J. Chromatogr.B877,421–432 (2009).
  Google Scholar
• 146  Aturki Z, D’Orazio G, Fanali S et al. Capillary electrochromatographic separation of illicit drugs employing a cyano stationary phase. J. Chromatogr. A (2008) (In press).
  MedlineGoogle Scholar
• 147  Jagerdeo E, Montgomery MA, Sibum M, Sasaki TA, LeBeau MA. Rapid analysis of cocaine and metabolites in urine using a completely automated solid-phase extraction–high-performance liquid chromatography-tandem mass spectrometry method. J. Anal. Toxicol.32,570–576 (2008).
  Medline CASGoogle Scholar
• 148  Su HL, Feng LI, Jen HP, Hsieh YZ. Determination of cocaine and its metabolites using cation-selective exhaustive injection and sweeping-MEKC. Electrophoresis29,4270–4276 (2008).
  Medline CASGoogle Scholar
• 149  Marchei E, Colone P, Nastasi GG et al. On-site screening and GC–MS analysis of cocaine and heroin metabolites in body-packers urine. J. Pharm. Biomed. Anal.48,383–387 (2008).
  Medline CASGoogle Scholar
• 150  Concheiro M, De Castro A, Quintela O, Cruz A, López-Rivadulla M. Determination of illicit drugs and their metabolites in human urine by liquid chromatography tandem mass spectrometry including relative ion intensity criterion. J. Anal. Toxicol.31,573–580 (2007).
  Medline CASGoogle Scholar
• 151  Feng J, Wang L, Dai I, Harmon T, Bernet JT. Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC–MS–MS. J. Anal. Toxicol.31,359–368 (2007).
  Medline CASGoogle Scholar
• 152  Schönberg L, Grobosch T, Lampe D, Kloft C. Toxicological Screening in Urine: Comparison of Two Automated HPLC Screening Systems, Toxicological Identification System (TOX.I.S.*) versus REMEDITM-HS. J. Anal. Toxicol.31,321–327 (2007).
  MedlineGoogle Scholar
• 153  Znaleziona J, Petr J, Maier V et al. Capillary electrophoresis as a verification tool for immunochemical drug screening. Biomed. Pap. Med. Fac. Univ .Palacky Olomouc Czech Repub.151,31–36 (2007).
  Medline CASGoogle Scholar
• 154  Zaitsu K, Miki A, Katagi M, Tsuchihashi H. Long-term stability of various drugs and metabolites in urine, and preventive measures against their decomposition with special attention to filtration sterilization. Forensic Sci. Int.174,189–196 (2008).
  Medline CASGoogle Scholar
• 155  Fernández P, Lago M, Lorenzo RA, Carro AM, Bermejo AM, Tabernero MJ. Microwave assisted extraction of drugs of abuse from human urine. J. Appl. Toxicol.27,373–379 (2007).
  Medline CASGoogle Scholar
• 156  Romberg RW, Jamerson MH, Klette KL. Rapid analysis of benzoylecgonine in urine by fast gas chromatography–mass spectrometry. J. Anal. Toxicol.30,554–558 (2006).
  Medline CASGoogle Scholar
• 157  Jufer R, Walsh SL, Cone EJ, Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J. Anal. Toxicol.30,458–462 (2006).
  Medline CASGoogle Scholar
• 158  Saito T, Mase H, Takeichi S, Inokuchi S. Rapid simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates in human urine by GC–MS. J. Pharm. Biomed. Anal.43,358–363 (2007).
  Medline CASGoogle Scholar
• 159  Moody DE, Fang WB, Andrenyak DM, Monti KM, Jones C. A comparative evaluation of the instant-view 5-panel test card with onTrak TesTcup pro 5: comparison with gas chromatography–mass spectrometry. J. Anal. Toxicol.30,50–56 (2006).
  Medline CASGoogle Scholar
• 160  Yonamine M, Sampaio MC. A high-performance thin-layer chromatographic technique to screen cocaine in urine samples. Leg. Med.8,184–187 (2006).
  Medline CASGoogle Scholar
• 161  Fang H, Zeng Z, Liu L, Pang D. On-line back-extraction field-amplified sample injection method for directly analyzing cocaine and thebaine in the extractants by solvent microextraction. Anal. Chem.78,1257–1263 (2006).
  Medline CASGoogle Scholar
• 162  Miller EI, Wylie FM, Oliver JS. Simultaneous detection and quantification of amphetamines, diazepam and its metabolites, cocaine and its metabolites, and opiates in hair by LC-ESI–MS–MS using a single extraction method. J. Anal. Toxicol.32,457–469 (2008).
  Medline CASGoogle Scholar
• 163  Vogliardi S, Favretto D, Frison G, Ferrara SD, Seraglia R, Traldi P. A fast screening MALDI method for the detection of cocaine and its metabolites in hair. J. Mass Spectrom.44,18–24 (2009).
  Medline CASGoogle Scholar
• 164  Hegstad S, Khiabani HZ, Kristoffersen L, Kunøe N, Lobmaier PP, Christophersen AS. Drug screening of hair by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol.32,364–372 (2008).
  Medline CASGoogle Scholar
• 165  Mercolini L, Mandrioli R, Saladini B, Conti M, Baccini C, Raggi MA. Quantitative analysis of cocaine in human hair by HPLC with fluorescence detection. J. Pharm. Biomed. Anal.48,456–461(2008).
  Medline CASGoogle Scholar
• 166  Stramesi C, Polla M, Vignali C, Zucchella A, Groppi A. Segmental hair analysis in order to evaluate driving performance. Forensic Sci. Int.176,34–37 (2008).
  Medline CASGoogle Scholar
• 167  Tsanaclis L, Wicks JF. Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci. Int.176,19–22 (2008).
  Medline CASGoogle Scholar
• 168  Míguez-Framil M, Moreda-Piñeiro A, Bermejo-Barrera P, López P, Tabernero MJ, Bermejo AM. Improvements on enzymatic hydrolysis of human hair for illicit drug determination by gas chromatography/mass spectrometry. Anal. Chem.79,8564–8570 (2007).
  Medline CASGoogle Scholar
• 169  Gottardo R, Fanigliulo A, Bortolotti F, De Paoli G, Pascali JP, Tagliaro F. Broad-spectrum toxicological analysis of hair based on capillary zone electrophoresis-time-of-flight mass spectrometry. J. Chromatogr. A1159,190–197 (2007).
  Medline CASGoogle Scholar
• 170  Klys M, Rojek S, Kulikowska J, Bozek E, Scisłowski M.Usefulness of multi-parameter opiates–amphetamines–cocainics analysis in hair of drug users for the evaluation of an abuse profile by means of LC-APCI–MS–MS. J. Chromatogr.B854,299–307 (2007).
  Google Scholar
• 171  Garcia-Bournissen F, Rokach B, Karaskov T, Koren G. Cocaine detection in maternal and neonatal hair: implications to fetal toxicology. Ther. Drug Monit.29,71–76 (2007).
  Medline CASGoogle Scholar
• 172  Gambelunghe C, Sommavilla M, Ferranti C et al. Analysis of anabolic steroids in hair by GC/MS/MS. Biomed. Chromatogr.21,369–375 (2007).
  Medline CASGoogle Scholar
• 173  Mieczkowski T, Kruger M. Interpreting the color effect of melanin on cocaine and benzoylecgonine assays for hair analysis: brown and black samples compared. J. Forensic Leg. Med.14,7–15 (2007).
  MedlineGoogle Scholar
• 174  Politi L, Zucchella A, Morini L, Stramesi C, Polettini A. Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users. Forensic Sci. Int. Oct 172,23–27 (2007).
  Medline CASGoogle Scholar
• 175  Cristoni S, Basso E, Gerthoux P et al. Surface-activated chemical ionization ion trap mass spectrometry for the analysis of cocaine and benzoylecgonine in hair after extraction and sample dilution. Rapid Commun. Mass Spectrom.21,2515–2523 (2007).
  Medline CASGoogle Scholar
• 176  Cordero R, Paterson S. Simultaneous quantification of opiates, amphetamines, cocaine and metabolites and diazepam and metabolite in a single hair sample using GC–MS. J. Chromatogr.B850,423–431 (2007).
  Google Scholar
• 177  Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing oral fluid – evaluation of sample devices. J. Anal. Toxicol.32,393–401 (2008).
  Medline CASGoogle Scholar
• 178  Fernández P, Morales L, Vázquez C, Lago M, Bermejo AM. Comparison of two extraction procedures for determination of drugs of abuse in human saliva by high-performance liquid chromatography. J. Appl. Toxicol.28,998–1003 (2008).
  Medline CASGoogle Scholar
• 179  Concheiro M, de Castro A, Quintela O, Cruz A, López–Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography–tandem mass spectrometry. Anal. Bioanal. Chem.391,2329–2338 (2008).
  Medline CASGoogle Scholar
• 180  Cone EJ, Clarke J, Tsanaclis L. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J. Anal. Toxicol.31,424–433 (2007).
  Medline CASGoogle Scholar
• 181  Concheiro M, de Castro A, Quintela O, Cruz A, López-Rivadulla M. Confirmation by LC–MS of drugs in oral fluid obtained from roadside testing. Forensic Sci. Int.170,156–162 (2007).
  Medline CASGoogle Scholar
• 182  Pujadas M, Pichini S, Civit E, Santamariña E, Perez K, de la Torre R. A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry. J. Pharm. Biomed. Anal.44,594–601(2007).
  Medline CASGoogle Scholar
• 183  Quintela O, Crouch DJ, Andrenyak DM. Recovery of drugs of abuse from the immunalysis Quantisal™ oral fluid collection device. J. Anal. Toxicol.30,614–616 (2006).
  Medline CASGoogle Scholar
• 184  Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend.87,258–267 (2007).
  Medline CASGoogle Scholar
• 185  Toennes SW, Steinmeyer S, Maurer HJ, Moeller MR, Kauert GF. Screening for drugs of abuse in oral fluid – correlation of analysis results with serum in forensic cases. J. Anal. Toxicol.29,22–27 (2005).
  Medline CASGoogle Scholar
• 186  Wylie FM, Torrance H, Anderson RA, Oliver JS. Drugs in oral fluid: part I. Validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci. Int.150,191–198 (2005).
  Medline CASGoogle Scholar
• 187  Wood M, Laloup M, Ramirez Fernandez M del M et al. Quantitative analysis of multiple illicit drugs preserved in oral fluid by solid-phase extraction and liquid chromatography–tandem mass spectrometry. Forensic Sci. Int.150,227–238 (2005).
  Medline CASGoogle Scholar
• 188  Bernhoft IM, Steentoft A, Johansen SS, Klitgaard NA, Larsen LB, Hansen LB. Drugs in injured drivers in Denmark. Forensic Sci. Int.150,181–189 (2005).
  Medline CASGoogle Scholar
• 189  Clauwaert K, Decaestecker T, Mortier K et al. The determination of cocaine, benzoylecgonine, and cocaethylene in small-volume oral fluid samples by liquid chromatography–quadrupole-time of- flight mass spectrometry. J. Anal. Toxicol.28,655–659 (2004).
  Medline CASGoogle Scholar
• 190  Cámpora P, Bermejo AM, Tabernero MJ, Fernández P. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography–positive chemical ionization-mass spectrometry (GC–PCI–MS). J. Anal. Toxicol.27,270–274 (2003).
  Medline CASGoogle Scholar
• 191  Fucci N, De Giovanni N, Chiarotti M. Simultaneous detection of some drugs of abuse in saliva samples by SPME technique. Forensic Sci. Int.134,40–45 (2003).
  Medline CASGoogle Scholar
• 192  Yonamine M, Tawil N, Moreau RL, Silva AO. Solid-phase micro-extraction-gas chromatography–mass spectrometry and headspace-gas chromatography of tetrahydrocannabinol, amphetamine, methamphetamine, cocaine and ethanol in saliva samples. J. Chromatogr.B789,73–78 (2003).
  Google Scholar
• 193  Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization–MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal. Chem.75,798–804 (2003).
  Medline CASGoogle Scholar
• 194  Cone EJ, Presley L, Lehrer M et al. Oral fluid testing for drugs of abuse: Positive prevalence rates by Intercept™ immunoassay screening and GC–MS–MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol.26,541–546 (2002).
  Medline CASGoogle Scholar
• 195  Samyn N, De Boeck G, Verstraete A. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J. Forensic Sci.47,1380–1387 (2002).
  Medline CASGoogle Scholar
• 196  Mortier KA, Maudens KE, Lambert WE et al. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry. J. Chromatogr. B. 779,321–330 (2002).
  CASGoogle Scholar
• 197  Samyn N, van Haeren C. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int. J. Legal Med.113,150–154 (2000).
  Medline CASGoogle Scholar
• 198  Fucci N, De Giovanni N, Scarlata S. Sweat testing in addicts under methadone treatment: an Italian experience. Forensic Sci. Int.174,107–110 (2008).
  Medline CASGoogle Scholar
• 199  Keller T, Keller A, Tutsch-Bauer E, Monticelli F. Application of ion mobility spectrometry in cases of forensic interest. Forensic Sci. Int.161,130–140 (2006).
  Medline CASGoogle Scholar
• 200  Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin. Chem.51,2085–2094 (2005).
  Medline CASGoogle Scholar
• 201  Liberty HJ, Johnson BD, Fortner N. Detecting cocaine use through sweat testing: multilevel modeling of sweat patch length-of-wear data. J. Anal. Toxicol.28,667–673 (2004).
  Medline CASGoogle Scholar
• 202  Uemura N, Nath RP, Harkey MR, Henderson GL, Mendelson J, Jones RT. Cocaine levels in sweat collection patches vary by location of patch placement and decline over time. J. Anal. Toxicol.28,253–259 (2004).
  Medline CASGoogle Scholar
• 203  Moody DE, Spanbauer AC, Taccogno JL, Smith EK. Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography – positive ion chemical ionization–mass spectrometry. J. Anal. Toxicol.28,86–93 (2004).
  Medline CASGoogle Scholar
• 204  Liberty HJ, Johnson BD, Fortner N, Randolph D. Detecting crack and other cocaine use with fastpatches. Addict. Biol. 8,191–200 (2003).
  Google Scholar
• 205  Kidwell DA, Kidwell JD, Shinohara F et al. Comparison of daily urine, sweat, and skin swabs among cocaine users. Forensic Sci. Int.133,63–78 (2003).
  Medline CASGoogle Scholar
• 206  Winhusen TM, Somoza EC, Singal B, Kim S, Horn PS, Rotrosen J. Measuring outcome in cocaine clinical trials: a comparison of sweat patches with urine toxicology and participant self-report. Addiction98,317–324 (2003).
  MedlineGoogle Scholar
• 207  Moody DE, Cheever ML. Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches. J. Anal. Toxicol.25,190–197 (2001).
  Medline CASGoogle Scholar
• 208  García-Algar O, Vall Combelles O, Puig Sola C et al. Prenatal exposure to drugs of abuse using meconium analysis in a low socioeconomic population in Barcelona. Na. Pediatr.70,145–152 (2009).
  Google Scholar
• 209  Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clin. Pharmacol. Ther.84,604–612 (2008).
  Medline CASGoogle Scholar
• 210  López P, Bermejo AM, Tabernero MJ, Fernández P, Alvarez I. Determination of cocaine and heroin with their respective metabolites in meconium by gas chromatography–mass spectrometry. J. Appl. Toxicol.27,464–471 (2007).
  Medline CASGoogle Scholar
• 211  Pichini S, Puig C, Zuccaro P et al. Assessment of exposure to opiates and cocaine during pregnancy in a Mediterranean city: preliminary results of the ‘‘Meconium Project’’. Forensic Sci. Int.153,59–65 (2005).
  Medline CASGoogle Scholar
• 212  Pichini S, Marchei E, Pacifici R, Pellegrini M, Lozano J, García-Algar O. Application of a validated high-performance liquid chromatography–mass spectrometry assay to the analysis of m- and p-hydroxybenzoylecgonine in meconium. J. Chromatogr. B820,151–156 (2005).
  Medline CASGoogle Scholar
• 213  Hajnal BL, Ferriero DM, Partridge JC, Dempsey DA, Good WV. Is exposure to cocaine or cigarette smoke during pregnancy associated with infant visual abnormalities? Dev. Med. Child. Neurol.46,520–525 (2004).
  MedlineGoogle Scholar
• 214  Pichini S, Pacifici R, Pellegrini M et al. Development and validation of a liquid chromatography–mass spectrometry assay for the determination of opiates and cocaine in meconium. J. Chromatogr.B794,281–292 (2003).
  Google Scholar
• 215  Vinner E, Vignau J, Thibault D et al. Hair analysis of opiates in mothers and newborns for evaluating opiate exposure during pregnancy. Forensic Sci. Int.133,57–62 (2003).
  Medline CASGoogle Scholar
• 216  Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch. Dis. Child. Fetal. Neonatal Ed.88,F98–F100 (2003).
  Medline CASGoogle Scholar
• 217  Lester BM, ElSohly M, Wright LL et al. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics107,309–317 (2001).
  Medline CASGoogle Scholar
• 218  Xia Y, Wang P, Bartlett MG, Solomon HM, Busch KL. An LC–MS–MS method for the comprehensive analysis of cocaine and cocaine metabolites in meconium. Anal. Chem.72,764–771 (2000).
  Medline CASGoogle Scholar
• 219  ElSohly MA, Kopycki W, Feng S, Murphy TP. Identification and analysis of the major metabolites of cocaine in meconium. J. Anal. Toxicol.23,446–451 (1999).
  Medline CASGoogle Scholar
• 220  ElSohly MA, Stanford DF, Murphy TP et al. Immunoassay and GC–MS procedures for the analysis of drugs of abuse in meconium. J. Anal. Toxicol.23,436–445 (1999).
  Medline CASGoogle Scholar
• 221  Ali EM, Edwards HG, Hargreaves MD, Scowen IJ. Raman spectroscopic investigation of cocaine hydrochloride on human nail in a forensic context. Anal. Bioanal. Chem.390,1159–1166 (2008).
  Medline CASGoogle Scholar
• 222  Stimpfl T, Reichel S. Distribution of drugs of abuse within specific regions of the human brain. Forensic Sci. Int.170,179–182 (2007).
  Medline CASGoogle Scholar
• 223  Pellegrini M, Casá A, Marchei E et al. Development and validation of a gas chromatography-mass spectrometry assay for opiates and cocaine in human teeth. J. Pharm Biomed. Anal.40,662–668 (2006).
  Medline CASGoogle Scholar
• 301  European Monitoring Centre for Drugs and Drug Addiction. 2008 Annual Report on the state of drugs problem in Europe (2008) www.emcdda.europa.eu/publications/annual-report/2008
  Google Scholar